Epperly Melissa B

CIK: 0001807359

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (24.1%)

Position reduction

Option Exercises (M)2 (6.9%)

Derivative conversions

Awards (A)14 (48.3%)

Compensation grants

Other (G, F, J, C, D, …)6 (20.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ROIV

Roivant Sciences Ltd.

Director

NAUT

Nautilus Biotechnology, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (29 total)

ROIV
Roivant Sciences Ltd.
Oct 23, 2026
Award(A)
Direct
513 shares-
ROIV
Roivant Sciences Ltd.
Oct 23, 2026
Tax Payment(F)
Direct
116 shares at avg. $36.49$4K
ROIV
Roivant Sciences Ltd.
Oct 1, 2026
Sale(S)
Direct
900 shares at avg. $36.57$33K
ROIV
Roivant Sciences Ltd.
Oct 1, 2026
Exercise(M)
Direct
17.8K shares at avg. $4.46$79K
ROIV
Roivant Sciences Ltd.
Oct 1, 2026
Sale(S)
Direct
16.9K shares at avg. $36.08$608K
ROIV
Roivant Sciences Ltd.
Sep 16, 2026
Award(A)
Direct
5.1K shares-
ROIV
Roivant Sciences Ltd.
Sep 15, 2026
Sale(S)
Direct
4.3K shares at avg. $39.65$172K
ROIV
Roivant Sciences Ltd.
Sep 15, 2026
Sale(S)
Direct
600 shares at avg. $40.38$24K
ROIV
Roivant Sciences Ltd.
Sep 10, 2026
Tax Payment(F)
Direct
2.2K shares at avg. $40.94$89K
ROIV
Roivant Sciences Ltd.
Jul 17, 2026
Award(A)
Direct
543 shares-
ROIV
Roivant Sciences Ltd.
Jun 29, 2026
Sale(S)
Direct
2.7K shares at avg. $34.71$95K
ROIV
Roivant Sciences Ltd.
Jun 29, 2026
Sale(S)
Direct
15K shares at avg. $34.32$515K
ROIV
Roivant Sciences Ltd.
Jun 29, 2026
Exercise(M)
Direct
17.8K shares at avg. $4.46$79K
NAUT
Nautilus Biotechnology, Inc.
Jun 18, 2026
Award(A)
Stock Option (Right to Buy)
Direct
45K shares-
ROIV
Roivant Sciences Ltd.
Apr 17, 2026
Award(A)
Direct
670 shares-
ROIV
Roivant Sciences Ltd.
Mar 16, 2026
Sale(S)
Direct
41.9K shares at avg. $28.68$1.2M
ROIV
Roivant Sciences Ltd.
Jan 20, 2026
Tax Payment(F)
Direct
54 shares at avg. $22.98$1K
ROIV
Roivant Sciences Ltd.
Jan 20, 2026
Award(A)
Direct
815 shares-
ROIV
Roivant Sciences Ltd.
Oct 20, 2025
Award(A)
Direct
1.1K shares-
ROIV
Roivant Sciences Ltd.
Sep 10, 2025
Award(A)
Direct
14.5K shares-
ROIV
Roivant Sciences Ltd.
Sep 10, 2025
Other(J)
Direct
1.7K shares at avg. $13.77$23K
ROIV
Roivant Sciences Ltd.
Jul 17, 2025
Award(A)
Direct
1.6K shares-
NAUT
Nautilus Biotechnology, Inc.
Jun 23, 2025
Award(A)
Stock Option (Right to Buy)
Direct
45K shares-
ROIV
Roivant Sciences Ltd.
Apr 17, 2025
Award(A)
Direct
1.8K shares-
ROIV
Roivant Sciences Ltd.
Jan 23, 2025
Tax Payment(F)
Direct
180 shares at avg. $11.21$2K

		Type	Shares	Price		Ownership
Oct 23, 2026	ROIV Roivant Sciences Ltd.	Award(A)	513	-	$0	Direct
Oct 23, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	116	$36.49	$4,233	Direct
Oct 1, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	900	$36.57	$32,913	Direct
Oct 1, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	17,750	$4.46	$79,165	Direct
Oct 1, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	16,850	$36.08	$607,948	Direct
Sep 16, 2026	ROIV Roivant Sciences Ltd.	Award(A)	5,054	-	$0	Direct
Sep 15, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	4,338	$39.65	$172,002	Direct
Sep 15, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	600	$40.38	$24,228	Direct
Sep 10, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	2,179	$40.94	$89,208	Direct
Jul 17, 2026	ROIV Roivant Sciences Ltd.	Award(A)	543	-	$0	Direct
Jun 29, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	2,748	$34.71	$95,383	Direct
Jun 29, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	15,002	$34.32	$514,869	Direct
Jun 29, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	17,750	$4.46	$79,165	Direct
Jun 18, 2026	NAUT Nautilus Biotechnology, Inc.	Award(A) Stock Option (Right to Buy)	45,000	-	-	Direct
Apr 17, 2026	ROIV Roivant Sciences Ltd.	Award(A)	670	-	$0	Direct
Mar 16, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	41,861	$28.68	$1,200,573	Direct
Jan 20, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	54	$22.98	$1,241	Direct
Jan 20, 2026	ROIV Roivant Sciences Ltd.	Award(A)	815	-	$0	Direct
Oct 20, 2025	ROIV Roivant Sciences Ltd.	Award(A)	1,056	-	-	Direct
Sep 10, 2025	ROIV Roivant Sciences Ltd.	Award(A)	14,524	-	-	Direct
Sep 10, 2025	ROIV Roivant Sciences Ltd.	Other(J)	1,661	$13.77	$22,872	Direct
Jul 17, 2025	ROIV Roivant Sciences Ltd.	Award(A)	1,609	-	-	Direct
Jun 23, 2025	NAUT Nautilus Biotechnology, Inc.	Award(A) Stock Option (Right to Buy)	45,000	-	-	Direct
Apr 17, 2025	ROIV Roivant Sciences Ltd.	Award(A)	1,847	-	-	Direct
Jan 23, 2025	ROIV Roivant Sciences Ltd.	Tax Payment(F)	180	$11.21	$2,018	Direct

1-25 of 29 transactions

About Epperly Melissa B,

Epperly Melissa B, (SEC CIK 0001807359) files insider reports with the SEC as Director of Roivant Sciences Ltd. (ROIV) and Director of Nautilus Biotechnology, Inc. (NAUT).

Signal8 holds 20 ownership filings by Epperly Melissa B,, all Form 4s, filed between Sep 12, 2024 and Oct 27, 2026. Those filings report 29 transactions, from Sep 10, 2024 to Oct 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Epperly Melissa B,'s filings is in LONDON.

Recent filings by Epperly Melissa B,

Oct 23, 2026: Grant or award of ROIV shares (Form 4, code A).
Oct 23, 2026: Tax withholding of ROIV shares (Form 4, code F).
Oct 1, 2026: Open-market sale of ROIV shares (Form 4, code S).
Oct 1, 2026: Option exercise of ROIV shares (Form 4, code M).
Oct 1, 2026: Open-market sale of ROIV shares (Form 4, code S).

Other insiders filing for Roivant Sciences Ltd. (ROIV)

Venker Eric, President & Immunovant CEO
Oren Ilan, Director
MOMTAZEE JAMES C, Director
Sukhatme Mayukh, President & CIO
Gline Matthew, CEO
Torti Frank, President and Vant Chair

How to read Form 4 transaction codes